---
title: "GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/558bae47-79b8-5703-a7bb-aa03220cc27d
json: https://whiteintel.dev/api/public/dossier/558bae47-79b8-5703-a7bb-aa03220cc27d
identifier: lei:213800CRQITWKFMAER64
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `lei:213800CRQITWKFMAER64`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/558bae47-79b8-5703-a7bb-aa03220cc27d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/558bae47-79b8-5703-a7bb-aa03220cc27d  

## Registry profile

- **Status:** ISSUED  
- **Legal form:** `H0PO`  
- **Source:** GLEIF  

## Cross-source identity

The same real-world entity, resolved across sources:

- **GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED** — companies_house_bulk · `oo:GB-COH-11721880` — https://whiteintel.dev/entity/9a18cd20-00b5-5c15-9e43-d29cafb31e52

## Ownership & control

### Owners / controllers

- **GSK PLC** (ultimate parent) — https://whiteintel.dev/entity/de540871-ee21-5bac-81ec-cef5c7b8c34c
- **GSK PLC** (parent) — https://whiteintel.dev/entity/de540871-ee21-5bac-81ec-cef5c7b8c34c

### UBO chain (walk to the ultimate owner)

1. **GSK PLC** — ultimate parent → *GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED*
1. **GSK PLC** — parent → *GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED*
1. **GLAXO GROUP LIMITED** — beneficial owner 100% → *GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED*
1. **GLAXO GROUP LIMITED** — beneficial owner 87.5% → *GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED*
2. **GSK PLC** — ultimate parent → *GLAXO GROUP LIMITED*
2. **GSK PLC** — parent → *GLAXO GROUP LIMITED*
2. **GLAXOSMITHKLINE FINANCE PLC** — beneficial owner 100% → *GLAXO GROUP LIMITED*
2. **Glaxosmithkline Finance Plc** — beneficial owner 87.5% → *GLAXO GROUP LIMITED*
3. **GLAXOSMITHKLINE HOLDINGS LIMITED** — beneficial owner 100% → *GLAXOSMITHKLINE FINANCE PLC*
3. **GLAXOSMITHKLINE HOLDINGS LIMITED** — beneficial owner 87.5% → *GLAXOSMITHKLINE FINANCE PLC*
3. **GSK PLC** — ultimate parent → *GLAXOSMITHKLINE FINANCE PLC*
3. **GLAXOSMITHKLINE HOLDINGS LIMITED** — parent → *GLAXOSMITHKLINE FINANCE PLC*
4. **GSK PLC** — beneficial owner 100% → *GLAXOSMITHKLINE HOLDINGS LIMITED*
4. **Gsk Plc** — beneficial owner 87.5% → *GLAXOSMITHKLINE HOLDINGS LIMITED*
4. **GSK PLC** — ultimate parent → *GLAXOSMITHKLINE HOLDINGS LIMITED*
4. **GSK PLC** — parent → *GLAXOSMITHKLINE HOLDINGS LIMITED*

## Company profile (live · UK Companies House)

- **Company number:** `11721880`
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 2018-12-11
- **Registered office:** GSK MEDICINES RESEARCH CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY
- **SIC:** 96090 - Other service activities n.e.c.

## Provenance

- GLEIF — https://search.gleif.org/#/record/213800CRQITWKFMAER64

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED**. Human view: https://whiteintel.dev/entity/558bae47-79b8-5703-a7bb-aa03220cc27d · Structured JSON: https://whiteintel.dev/api/public/dossier/558bae47-79b8-5703-a7bb-aa03220cc27d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._